Загрузка...
SR 4233 (tirapazamine): a new anticancer drug exploiting hypoxia in solid tumours.
SR 4233 (3-amino-1,2,4-benzotriazine 1,4-dioxide, WIN 59075, tirapazamine) is the lead compound in a new class of bioreductive anticancer drugs, the benzotriazine di-N-oxides. It is currently undergoing Phase I clinical testing. The preferential tumour cell killing of SR 4233 is a result of its high...
Сохранить в:
| Главный автор: | |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Nature Publishing Group
1993
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1968495/ https://ncbi.nlm.nih.gov/pubmed/8512801 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|